Series A

With its 'Infinite Ways to Earn' campaign, Mu Digital plans to tokenize Asia's vast credit market on the Monad blockchain, offering new, stable yields.

Wendel Investment Managers' affiliates raise over €11 billion, validating the firm's strategic pivot and defying a tough private capital market.

Crosswalk Therapeutics secures a key grant to develop a therapy targeting the debilitating skeletal disease in Morquio A, a challenge current treatments can't solve.

Amid a rebounding SPAC market, FG Imperii Acquisition Corp. launches a $200M IPO, targeting North America's financial services sector with a veteran team.

With a new CEO, $15M in funding, and rapid U.S. expansion, Canadian brand Cove Soda is poised to shake up the booming healthy beverage market.

A new bio-based adhesive from BioBond aims to replace screws and welding in defense and mobility, promising high performance and rural job growth.

Two Shark Tank alumni, Like Air and Copper Cow Coffee, unveil a Vietnamese Coffee Puffcorn, leveraging social commerce to redefine snack innovation.

The investment firm celebrated a strong 2025 with shareholder payouts, fueled by profitable exits and a new major investment in AI infrastructure firm TensorWave.

Biotech veteran Kamran Tavangar, who built a multi-billion dollar company at LabCentral, returns to lead its science strategy and shape the future of innovation.

With $6.5M CAD in new funding, Montréal's AI4Eyes is set to accelerate the global launch of its all-in-one diagnostic and treatment platform.

With a new board chair, regulatory backing, and an AI platform, GC Therapeutics is targeting MS and diabetes with next-generation cell therapies.

Amid strong investor demand, VR Resources boosts its financing and plans a share consolidation to fuel its key copper, gold, and tungsten projects in Nevada.

A new campaign says indecision is the biggest business risk. Aily Labs' AI platform promises to end analysis paralysis and force confident, fast action.

Record AI mega-deals redefine healthcare innovation, yet a broader market contraction creates a new divide for startups and traditional medical sectors.

Defense tech startup Vatn Systems acquires Crewless Marine, a strategic move to vertically integrate key sensor technology and accelerate its rise in naval warfare.

Kelonia Therapeutics gets the FDA green light to expand trials for its in vivo CAR-T therapy, a single-infusion treatment that could redefine cancer care.

A new universal operating system and app store, QwikOS, launches to standardize humanoid robots, making them more accessible to developers and users.

As businesses wait years for grid upgrades, a new partnership deploys mobile battery systems to power the stalled growth of EVs and data centers.

Prenetics slashed future dilution risk by exchanging 4.7M warrants, a move analysts see as crucial for fueling the rapid growth of its IM8 wellness brand.

Abingworth elevates Bali Muralidhar and hires Travis Wilson, signaling a major push into clinical co-development and buyouts under Carlyle's wing.